Myapplepharma

Hertab 250mg (Lapatinib) tablets are classified as anti-cancer agent, which is orally active drug used for treating breast cancer, Chemically classified as quinazoline with strong anti-cancer effect and the tablet.

Hertab tablets are classified as anti-cancer agent, which is orally active drug used for treating breast cancer.

Chemically classified as quinazoline with strong anti-cancer effect and the tablet Hertab is a synthetic oral tablet.

Normally targeted therapy or tyrosine kinase inhibitor drugs can increase the plasma amino transferase levels which may leads to liver injury.

Hertab tablets are classified as;

1. Tyrosine kinase prohibitor

2. Stop the HER2/neu & epidermal growth factor receptor activity

3. Targeted therapy

4. Signal transduction prohibitor

PRODUCT DETAILS

Brand Name : Hertab

Composition : Lapatinib

Strength availability : 250mg

Manufactured by : Hetero

Pack : 150 tablets

Liver damage:

Raising level of AST, ALT or bilirubin may cause liver injury

To inhibits this condition, periodic LFT should be control

Diarrhea:

Serious diarrhea may cause to dehydration leads death also; if patient do not recover from this severity must stop with this therapy.

Interstitial lung disease:

Patient should be check with pulmonary symptoms and give supportive measures.

On Serious condition, treatment should be discontinuing

QT prolongation:

Balance ECG periodically

Give the patient substituent for this adverse condition

Hypokalemia and hypomagnesemia correction should be takes place

Cutaneous reactions:

Some life-threatening reactions may occur, in this condition therapy should be discontinued

Embryo fetal damage:

Hertab leads to fetal damage and produce some deformities.

During therapy Patient should advice not getting pregnant.